|
Volumn 277, Issue 37, 2002, Pages 33791-33798
|
Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASES;
ENZYME INHIBITION;
MUTAGENESIS;
PROTEINS;
HUNTINGTON'S DISEASE;
TOXICITY;
2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE;
BETA CATENIN;
CHAPERONE;
ENZYME INHIBITOR;
GLYCOGEN SYNTHASE KINASE 3BETA;
GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR;
GREEN FLUORESCENT PROTEIN;
HEAT SHOCK PROTEIN 27;
HEAT SHOCK PROTEIN 70;
LITHIUM CHLORIDE;
POLYGLUTAMINE;
TRANSCRIPTION FACTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
ENZYME INHIBITION;
GENE MUTATION;
GENETIC DISORDER;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
HUNTINGTON CHOREA;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
BETA CATENIN;
CELL AGGREGATION;
CELL DEATH;
COS CELLS;
CYTOSKELETAL PROTEINS;
ENZYME INHIBITORS;
GLYCOGEN SYNTHASE KINASE 3;
HEAT-SHOCK PROTEINS;
HSP70 HEAT-SHOCK PROTEINS;
HUMANS;
HUNTINGTON DISEASE;
INDOLES;
LITHIUM CHLORIDE;
MALEIMIDES;
MUTATION;
NEOPLASM PROTEINS;
PEPTIDES;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TRANS-ACTIVATORS;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0037072807
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M204861200 Document Type: Article |
Times cited : (199)
|
References (33)
|